Latest & greatest articles for tuberculosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on tuberculosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on tuberculosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for tuberculosis

121. Peritoneal tuberculosis with elevated CA-125 mimicking ovarian cancer with carcinomatosis peritonei: Crucial CT findings

Peritoneal tuberculosis with elevated CA-125 mimicking ovarian cancer with carcinomatosis peritonei: Crucial CT findings 28337102 2018 11 13 1611-2156 15 2016 EXCLI journal EXCLI J Peritoneal tuberculosis with elevated CA-125 mimicking ovarian cancer with carcinomatosis peritonei: Crucial CT findings. 711-715 10.17179/excli2016-625 Preoperative diagnosis of peritoneal tuberculosis is often difficult because of confusion with ovarian cancer. A 56-year-old woman was admitted to our hospital (...) with abdominal fullness. Ascites, prominent bilateral ovaries, and elevated CA-125 were noted. Computed tomography showed thickened peritoneum and strandings in the mesentery and omentum. Exploratory laparotomy was performed under the provisional diagnosis of ovarian cancer, but the final diagnosis was peritoneal tuberculosis. Careful evaluation of bilateral fallopian tubes and ovaries and peritoneum are helpful for correct diagnosis. Chien Jerry Chin-Wei JC Department of Radiology, Wan Fang Hospital, Taipei

EXCLI journal2016 Full Text: Link to full Text with Trip Pro

122. Diabetes Mellitus as Hub for Tuberculosis Infection: A Snapshot

Diabetes Mellitus as Hub for Tuberculosis Infection: A Snapshot 27819024 2018 11 13 2356-6981 2016 2016 International journal of chronic diseases Int J Chronic Dis Diabetes Mellitus as Hub for Tuberculosis Infection: A Snapshot. 5981574 Tuberculosis (TB) still remains the thorn in the flesh of efficient therapeutics affecting one-third of global population annually. There are several factors that enhance the susceptibility to TB infections including malnutrition, smoking, and immunocompromised (...) University Haryana, Gurgaon, Manesar 122413, India. eng Review Journal Article 2016 10 12 Egypt Int J Chronic Dis 101654921 2314-5749 Clin Infect Dis. 2005 Aug 1;41(3):281-8 16007521 Trop Med Int Health. 2010 Nov;15(11):1289-99 20955495 Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):53-64 15687028 Scand J Immunol. 2006 Feb;63(2):142-50 16476014 Int J Tuberc Lung Dis. 2006 Jan;10(1):74-9 16466041 FEMS Immunol Med Microbiol. 1999 Dec;26(3-4):259-65 10575137 Immunology. 1986 Jan;57(1):159-63 3002968 Lancet

International journal of chronic diseases2016 Full Text: Link to full Text with Trip Pro

123. Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.

Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland. BACKGROUND: Tuberculosis elimination in countries with a low incidence of the disease necessitates multiple interventions, including innovations in migrant screening. We examined a cohort of migrants screened for tuberculosis before entry to England, Wales, and Northern Ireland and tracked (...) the development of disease in this group after arrival. METHODS: As part of a pilot pre-entry screening programme for tuberculosis in 15 countries with a high incidence of the disease, the International Organization for Migration screened all applicants for UK visas aged 11 years or older who intended to stay for more than 6 months. Applicants underwent a chest radiograph, and any with results suggestive of tuberculosis underwent sputum testing and culture testing (when available). We tracked the development

Lancet2016 Full Text: Link to full Text with Trip Pro

124. Psychosocial wellbeing of patients with multidrug resistant tuberculosis voluntarily confined to long-term hospitalisation in Nigeria

Psychosocial wellbeing of patients with multidrug resistant tuberculosis voluntarily confined to long-term hospitalisation in Nigeria 28588950 2018 11 13 2059-7908 1 3 2016 BMJ global health BMJ Glob Health Psychosocial wellbeing of patients with multidrug resistant tuberculosis voluntarily confined to long-term hospitalisation in Nigeria. e000006 10.1136/bmjgh-2015-000006 Patient isolation, which is a widely successful treatment strategy for tuberculosis (TB), has been suspected to have (...) of Medicine Ikeja Lagos, Ikeja, Lagos, Nigeria. Lawson Lovett L Department of Community Medicine and Primary Healthcare, Bingham University, Nasarawa, Nigeria. Eltayeb Osman O Damien Foundation Belgium, Nigeria. Gidado Mustapha M Programme Management Unit, KNCV Tuberculosis Foundation, Nigeria. Tsoka-Gwegweni Joyce M JM Discipline of Public Health Medicine, College of Health Science, Howard College Campus, University of KwaZulu-Natal, Durban, South Africa. Ihekweazu Chikwe A CA Nigeria Center for Disease

BMJ global health2016 Full Text: Link to full Text with Trip Pro

126. Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study.

Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study. BACKGROUND: Acquisition and persistence of tuberculosis infection are important epidemiological measurements for evaluation of tuberculosis transmission in a community. However, prospective population data on the incidence of tuberculosis infection have been sparely reported in the global literature. METHODS: We conducted a population-based, multicentre (...) , prospective study to investigate the annual risk of tuberculosis infection and its persistence in rural populations in China from July 2013 to June 2015, using yearly tests with tuberculin skin test (TST) and an interferon-γ release assay (IGRA). FINDINGS: 15 907 eligible participants from four rural sites (Xiangtan, Hunan province; Zhongmu, Henan Province; Longxi, Gansu Province; Danyang, Jiangsu Province) who were identified as TST-negative (<10 mm) or IGRA-negative in a baseline survey were included

Lancet2016 Full Text: Link to full Text with Trip Pro

127. Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults

Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults 28588939 2018 11 13 2059-7908 1 2 2016 BMJ global health BMJ Glob Health Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults. e000064 10.1136/bmjgh-2016-000064 Systematic screening is often proposed as a way to improve case finding for tuberculosis (TB), but the cost-effectiveness of specific strategies for systematic (...) 16343340 N Engl J Med. 1999 Feb 11;340(6):448-54 9971870 PLoS One. 2015 Feb 06;10(2):e0117009 25658592 Afr Health Sci. 2010 Dec;10(4):320-4 21416032 Glob Health Action. 2015 Mar 27;8:27048 25819037 Competing interests: AC reports involvement in studies funded by NIH and PEPFAR on the utility of C reactive protein as a screening test for tuberculosis among people living with HIV. CD reports employment by FIND. 2016 04 18 2016 07 12 2016 07 26 2017 6 8 6 0 2017 6 8 6 0 2017 6 8 6 1 epublish 28588939

BMJ global health2016 Full Text: Link to full Text with Trip Pro

128. Multidrug-resistant tuberculosis and migration to Europe

Multidrug-resistant tuberculosis and migration to Europe WHO IRIS: Multidrug-resistant tuberculosis and migration to Europe Browse Related links Files in This Item: No electronic version is available yet. Title: Multidrug-resistant tuberculosis and migration to Europe Authors: Issue Date: 22-Sep-2016 Language: English Abstract: Multidrug-resistant tuberculosis (MDR-TB) in low-incidence countries in Europe is more prevalent among migrants than the native population. The impact of the recent

WHO2016

129. Hematological and liver toxicity of anti-tuberculosis drugs

Hematological and liver toxicity of anti-tuberculosis drugs 27790357 2018 11 13 2008-5842 8 9 2016 Sep Electronic physician Electron Physician Hematological and liver toxicity of anti-tuberculosis drugs. 3005-3010 Tuberculosis (TB) is a major global health problem, and anti-tuberculosis drugs can cause severe adverse reactions. The aim of this study was to determine hematological and biochemical changes and associated risk factors in smear positive pulmonary tuberculosis patients undergoing (...) treatment with standard protocols. In a descriptive study, a total of 40 tuberculosis patients aged between 15-60 years were collected from hospitals in Khuzestan Province (Iran) from March 2013 to March 2014. The patients were treated with drugs (isoniazid, rifampicin, ethambutol, and pyrazinamide) during the initial two months, followed by isoniazid and rifampicin for the next four to six months. Activities of liver enzymes (ALT, AST, and ALP) and hematological parameters were recorded before

Electronic physician2016 Full Text: Link to full Text with Trip Pro

130. GenoType<sup>®</sup> MTBDRsl assay for resistance to second-line anti-tuberculosis drugs.

GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs. BACKGROUND: Genotype® MTBDRsl (MTBDRsl) is a rapid DNA-based test for detecting specific mutations associated with resistance to fluoroquinolones and second-line injectable drugs (SLIDs) in Mycobacterium tuberculosis complex. MTBDRsl version 2.0 (released in 2015) identifies the mutations detected by version 1.0, as well as additional mutations. The test may be performed on a culture isolate or a patient (...) specimen, which eliminates delays associated with culture. Version 1.0 requires a smear-positive specimen, while version 2.0 may use a smear-positive or -negative specimen. We performed this updated review as part of a World Health Organization process to develop updated guidelines for using MTBDRsl. OBJECTIVES: To assess and compare the diagnostic accuracy of MTBDRsl for: 1. fluoroquinolone resistance, 2. SLID resistance, and 3. extensively drug-resistant tuberculosis, indirectly on a M. tuberculosis

Cochrane2016 Full Text: Link to full Text with Trip Pro

131. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement.

Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. IMPORTANCE: Tuberculosis remains an important preventable disease in the United States. An effective strategy for reducing the transmission, morbidity, and mortality of active disease is the identification and treatment of latent tuberculosis infection (LTBI) to prevent progression to active disease. OBJECTIVE: To issue a current US Preventive Services Task Force (USPSTF

JAMA2016 Full Text: Link to full Text with Trip Pro

132. Chronic heel pain: It could be tuberculosis

Chronic heel pain: It could be tuberculosis 28461854 2018 11 13 1985-207X 11 2-3 2016 Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia Malays Fam Physician Chronic heel pain: It could be tuberculosis. 20-23 Heel pain is a common presentation at a primary care setting. The majority of these cases are benign and self limiting in nature. Common differential diagnoses include plantar fasciitis and peroneal muscle sprains. However, certain conditions (...) -if undetected early-may cause significant morbidity to the patient. A high index of suspicion and early referral for further investigations are needed to prevent long-term morbidities. A clinical review of a patient with chronic left heel pain was performed. Blood parameters and imaging investigations indicated chronic infection of the calcaneum. Histopathological examination was highly suggestive of tuberculosis. The patient responded well to antituberculous therapy. She was pain free and showed no signs

Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia2016 Full Text: Link to full Text with Trip Pro

133. Head and neck tuberculosis: The great mimic

Head and neck tuberculosis: The great mimic 28461859 2018 11 13 1985-207X 11 2-3 2016 Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia Malays Fam Physician Head and neck tuberculosis: The great mimic. 38 Mohamad I I MD, M.Med (ORL-HNS), School of Medical Sciences, Universiti Sains Malaysia Health Campus, Kelantan, Malaysia, email:irfankb@usm.my. Nik Hassan Nfh N MD, M.Med (ORL-HNS), School of Health Sciences, Universiti Sains Malaysia Health (...) Otolaryngology Tuberculosis Tuberculosis vaccines 2017 5 3 6 0 2017 5 4 6 0 2017 5 4 6 1 epublish 28461859 PMC5408878

Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia2016 Full Text: Link to full Text with Trip Pro

134. HIV and tuberculosis in prisons in sub-Saharan Africa.

HIV and tuberculosis in prisons in sub-Saharan Africa. Given the dual epidemics of HIV and tuberculosis in sub-Saharan Africa and evidence suggesting a disproportionate burden of these diseases among detainees in the region, we aimed to investigate the epidemiology of HIV and tuberculosis in prison populations, describe services available and challenges to service delivery, and identify priority areas for programmatically relevant research in sub-Saharan African prisons. To this end, we (...) reviewed literature on HIV and tuberculosis in sub-Saharan African prisons published between 2011 and 2015, and identified data from only 24 of the 49 countries in the region. Where data were available, they were frequently of poor quality and rarely nationally representative. Prevalence of HIV infection ranged from 2·3% to 34·9%, and of tuberculosis from 0·4 to 16·3%; detainees nearly always had a higher prevalence of both diseases than did the non-incarcerated population in the same country. We

Lancet2016 Full Text: Link to full Text with Trip Pro

135. Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.

Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. The burden of HIV/AIDS and other transmissible diseases is higher in prison and jail settings than in the non-incarcerated communities that surround them. In this comprehensive review, we discuss available literature on the topic of clinical management of people infected with HIV, hepatitis B and C viruses, and tuberculosis in incarcerated settings in addition to co-occurrence of one or more of these infections

Lancet2016 Full Text: Link to full Text with Trip Pro

136. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.

Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. The prison setting presents not only challenges, but also opportunities, for the prevention and treatment of HIV, viral hepatitis, and tuberculosis. We did a comprehensive literature search of data published between 2005 and 2015 to understand the global epidemiology of HIV, hepatitis C virus (HCV), hepatitis B virus (HBV), and tuberculosis in prisoners. We further modelled the contribution of imprisonment (...) and the potential impact of prevention interventions on HIV transmission in this population. Of the estimated 10·2 million people incarcerated worldwide on any given day in 2014, we estimated that 3·8% have HIV (389 000 living with HIV), 15·1% have HCV (1 546 500), 4·8% have chronic HBV (491 500), and 2·8% have active tuberculosis (286 000). The few studies on incidence suggest that intraprison transmission is generally low, except for large-scale outbreaks. Our model indicates that decreasing the incarceration

Lancet2016

137. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.

The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Despite global reductions in HIV incidence and mortality, the 15 UNAIDS-designated countries of Eastern Europe and Central Asia (EECA) that gained independence from the Soviet Union in 1991 constitute the only region where both continue to rise. HIV transmission in EECA is fuelled primarily by injection of opioids, with harsh (...) criminalisation of drug use that has resulted in extraordinarily high levels of incarceration. Consequently, people who inject drugs, including those with HIV, hepatitis C virus, and tuberculosis, are concentrated within prisons. Evidence-based primary and secondary prevention of HIV using opioid agonist therapies such as methadone and buprenorphine is available in prisons in only a handful of EECA countries (methadone or buprenorphine in five countries and needle and syringe programmes in three countries

Lancet2016 Full Text: Link to full Text with Trip Pro

138. Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.

Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. The prevalence of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis are higher in prisons than in the general population in most countries worldwide. Prisons have emerged as a risk environment for these infections to be further concentrated, amplified, and then transmitted to the community after prisoners are released. In the absence of alternatives to incarceration, prisons

Lancet2016

139. β-Lactams against Tuberculosis - New Trick for an Old Dog?

β-Lactams against Tuberculosis - New Trick for an Old Dog? β-Lactams against Tuberculosis--New Trick for an Old Dog? - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 27433841 Format MeSH and Other Data E-mail (...) Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2016 Jul 28;375(4):393-4. doi: 10.1056/NEJMc1513236. Epub 2016 Jul 13. β-Lactams against Tuberculosis--New Trick for an Old Dog? 1 , 2 , 2 , 2 , 3 , 4 , 5 , 6 , 6 . 1 Stellenbosch University, Cape Town, South Africa ahd@sun.ac.za. 2 Task Applied Science, Cape Town, South Africa. 3 Research Center Borstel, Borstel

NEJM2016 Full Text: Link to full Text with Trip Pro

140. Tuberculosis and AIDS: major progress

Tuberculosis and AIDS: major progress Prescrire IN ENGLISH - Spotlight ''Tuberculosis and AIDS: major progress'', 1 July 2016 {1} {1} {1} | | > > > Tuberculosis and AIDS: major progress Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Tuberculosis and AIDS: major progress AIDS and tuberculosis still rank among the leading causes of death worldwide

Prescrire2016